Replies to post #417490 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

Such an publication would demonstrate that the MOA of 2-73 is valid. At that point investors will take the broad applicability of 2-73 seriously and recognize how many other indications that 2-73 could treat. Number crunching will immediately follow.

[Hoskuld]

Do you really need a peer-reviewed journal article? I don't think you do. And it is not what "equity buyers" are looking for. No one cares about those articles right now. The only thing that matters is data and NDA approvals.